Management of Portal Hypertension and Ascites in Polycystic Liver Disease

Overview

Journal Liver Int

Specialty Gastroenterology

Date 2019 Sep 11

PMID 31505092

Citations 11

Authors

Lucas H P Bernts

Joost P H Drenth

Eric T T L Tjwa

Affiliations

Soon will be listed here.

Abstract

Patients suffering from polycystic liver disease may develop Hepatic Venous Outflow Obstruction, Portal Vein Obstruction and/or Inferior Caval Vein Syndrome because of cystic mass effect. This can cause portal hypertension, leading to ascites, variceal haemorrhage or splenomegaly. For this review, we evaluate the evidence to provide clinical guidance for physicians faced with this complication. Diagnosis is made with imaging such as ultrasound, computed tomography or magnetic resonance imaging. Therapy includes conventional therapy with diuretics and paracentesis, and medical therapy using somatostatin analogues. Based on disease phenotype various (non-)surgical liver-volume reducing therapies, hepatic or portal venous stenting, transjugular intrahepatic portosystemic shunts and liver transplantation may be considered. Because of complicated anatomy, use of high-risk interventions and lack of empirical evidence, patients should be treated in expert centres.

Citing Articles

Questionnaire PLD-complaint-specific assessment identifies need for therapy in polycystic liver disease: A multi-centric prospective study.

Billiet A, Temmerman F, Coudyzer W, Van den Ende N, Colle I, Francque S United European Gastroenterol J. 2023; 11(7):633-641.

PMID: 37278135 PMC: 10493353. DOI: 10.1002/ueg2.12387.

Fatal acute portal vein thrombosis associated with hepatic cysts in a patient with autosomal dominant polycystic kidney disease.

Tsuchida Y, Tsubata Y, Nozawa R, Maruyama S, Ikarashi K, Saito N CEN Case Rep. 2023; 13(1):32-36.

PMID: 37162720 PMC: 10834907. DOI: 10.1007/s13730-023-00795-6.

Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment.

Norcia L, Watanabe E, Hamamoto Filho P, Hasimoto C, Pelafsky L, de Oliveira W Hepat Med. 2022; 14:135-161.

PMID: 36200122 PMC: 9528914. DOI: 10.2147/HMER.S377530.

Surgical treatment of hepatic xanthogranuloma arising from a giant hepatic cyst causing gastrointestinal obstruction: a case report.

Kohata A, Inoue M, Nomimura K, Matsubara K, Kochi M, Hotta R J Surg Case Rep. 2022; 2022(7):rjac252.

PMID: 35919696 PMC: 9341229. DOI: 10.1093/jscr/rjac252.

An emergency hybrid procedure that combines endoscopic treatment with partial splenic embolization for bleeding esophagogastric varices.

Chikamori F, Maeda A, Sharma N Radiol Case Rep. 2022; 17(5):1640-1645.

PMID: 35342491 PMC: 8943213. DOI: 10.1016/j.radcr.2022.02.041.

References

Puhl G, Gul S, Neuhaus P . [Portosystemic shunt surgery between TIPS and liver transplantation]. Chirurg. 2011; 82(10):898-905. DOI: 10.1007/s00104-011-2100-1. View

Dengu F, Azhar B, Patel S, Hakim N . Bilateral Nephrectomy for Autosomal Dominant Polycystic Kidney Disease and Timing of Kidney Transplant: A Review of the Technical Advances in Surgical Management of Autosomal Dominant Polycystic Disease. Exp Clin Transplant. 2015; 13(3):209-13. View

Khan M, Khan Z, Javaid T, Akhtar J, Moustafa A, Lal A . Isolated Polycystic Liver Disease: An Unusual Cause of Recurrent Variceal Bleed. Case Rep Gastrointest Med. 2018; 2018:2902709. PMC: 6008945. DOI: 10.1155/2018/2902709. View

Gigot J, Jadoul P, Que F, Van Beers B, Etienne J, Horsmans Y . Adult polycystic liver disease: is fenestration the most adequate operation for long-term management?. Ann Surg. 1997; 225(3):286-94. PMC: 1190679. DOI: 10.1097/00000658-199703000-00008. View

Hiramine Y, Uto H, Mawatari S, Kanmura S, Imamura Y, Hiwaki T . Effect of tolvaptan on the prognosis of patients with hepatic ascites. Hepatol Res. 2019; 49(7):765-777. DOI: 10.1111/hepr.13337. View

Mancinelli R, Franchitto A, Glaser S, Vetuschi A, Venter J, Sferra R . Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease. Lab Invest. 2016; 96(11):1147-1155. PMC: 5480400. DOI: 10.1038/labinvest.2016.93. View

Misra A, Loyalka P, ALVA F . Portal hypertension due to extensive hepatic cysts in autosomal dominant polycystic kidney disease. South Med J. 1999; 92(6):626-7. DOI: 10.1097/00007611-199906000-00015. View

Mazza O, Fernandez D, Pekolj J, Pfaffen G, Sanchez Claria R, Molmenti E . Management of nonparasitic hepatic cysts. J Am Coll Surg. 2009; 209(6):733-9. DOI: 10.1016/j.jamcollsurg.2009.09.006. View

Procopet B, Berzigotti A . Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep (Oxf). 2017; 5(2):79-89. PMC: 5421457. DOI: 10.1093/gastro/gox012. View

10.

Belcher H, Wright P, Rose J . Case report: variceal haemorrhage due to polycystic liver treated by transhepatic intervention. Clin Radiol. 1996; 51(10):732-4. DOI: 10.1016/s0009-9260(96)80249-2. View

11.

Lin H, Tsai Y, Lee F, Lee S, Hsia H, Lin W . Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis. Gastroenterology. 1992; 103(1):229-34. DOI: 10.1016/0016-5085(92)91117-m. View

12.

Kabbej M, Sauvanet A, Chauveau D, Farges O, Belghiti J . Laparoscopic fenestration in polycystic liver disease. Br J Surg. 1996; 83(12):1697-701. DOI: 10.1002/bjs.1800831211. View

13.

van Keimpema L, Nevens F, Adam R, Porte R, Fikatas P, Becker T . Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study. Transpl Int. 2011; 24(12):1239-45. DOI: 10.1111/j.1432-2277.2011.01360.x. View

14.

Chapman A, Devuyst O, Eckardt K, Gansevoort R, Harris T, Horie S . Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2015; 88(1):17-27. PMC: 4913350. DOI: 10.1038/ki.2015.59. View

15.

Neijenhuis M, Gevers T, Atwell T, Gunneson T, Schimek A, Kievit W . Development and Validation of a Patient-Reported Outcome Measurement for Symptom Assessment in Cirrhotic Ascites. Am J Gastroenterol. 2018; 113(4):567-575. DOI: 10.1038/ajg.2018.18. View

16.

Kirkman M, van Dellen D, Mehra S, Campbell B, Tavakoli A, Pararajasingam R . Native nephrectomy for autosomal dominant polycystic kidney disease: before or after kidney transplantation?. BJU Int. 2010; 108(4):590-4. DOI: 10.1111/j.1464-410X.2010.09938.x. View

17.

Grams J, Teh S, Torres V, Andrews J, Nagorney D . Inferior vena cava stenting: a safe and effective treatment for intractable ascites in patients with polycystic liver disease. J Gastrointest Surg. 2007; 11(8):985-90. DOI: 10.1007/s11605-007-0182-3. View

18.

Guyatt G, Oxman A, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924-6. PMC: 2335261. DOI: 10.1136/bmj.39489.470347.AD. View

19.

Bernts L, Tjwa E, DAgnolo H, Jenniskens S, Drenth J . Venous Stent Placement for Refractory Ascites due to Hepatic Venous Outflow Obstruction in Polycystic Liver Disease. J Vasc Interv Radiol. 2019; 30(10):1617-1619. DOI: 10.1016/j.jvir.2018.09.011. View

20.

Bernts L, Drenth J, Tjwa E . Management of portal hypertension and ascites in polycystic liver disease. Liver Int. 2019; 39(11):2024-2033. PMC: 6899472. DOI: 10.1111/liv.14245. View